Mitochondria and diabetes: Genetic, biochemical, and clinical implications of the cellular energy circuit

Diabetes

Volumn 45, Issue 2, 1996, Pages 113-126

  Gerbitz, Klaus Dieter ^a   Gempel, Klaus ^a   Brdiczka, Dieter ^b  

^a Klinikum Schwabing   (Germany)

^b UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; GLUCOSE 6 PHOSPHATE; HEXOKINASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE;

ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; ENZYME ACTIVITY; GENETIC PREDISPOSITION; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; MITOCHONDRIAL MEMBRANE; NON INSULIN DEPENDENT DIABETES MELLITUS; POINT MUTATION; PRIORITY JOURNAL; TISSUE SPECIFICITY;

EID: 0030046495     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.45.2.113     Document Type: Article

References (151)

1. Vionnet N, Stoffel M, Takeda J, Yasuda K, Bell GI, Zouah H, Lesage S, Velho G, Iris F, Pass P, Frouguel P, Cohen D. Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus. Nature 356:721-722, 1992
2. Gerbitz KD: Does the mitochondrial DNA play a role in the development of diabetes? Diabetalogia 35:1181-1186, 1992
3. Orci L, Thorens B, Ravazzola M, Lodish HF: Localization of pancreatic beta cell glucose transporter to specific plasma membrane domains. Science 245:295-297, 1989
4. m glucose transporter of islets of Langerhans is functionally similar to the low affinity transporter of liver and has an identical primary sequence. J Biol Chem 265:6548-6551, 1990
5. Meglasson MD, Matschinsky FM: New perspectives on pancreatic islet glucokinase Am J Physiol 246:E1-E13, 1984
6. Matschinsky F, Liang Y, Keavan P, Wang L, Froguel P, Velho G, Cohen D, Permutt MA, Tanizawa Y, Jetton TL, Niswender K, Magnuson MA: Glucokinase as pancreatic β-cell, glucose sensor and diabetes gene. J Clin Invest 2:2092-2098, 1993
7. Epstein P, Boschero A, Atwater I, Cai X, Overbeek P: Expression of yeast hexokinase in pancreatic β-cells of transgenic mice reduces blood glucose, enhances insulin secretion and decreases diabetes. Proc Natl Acad Sci USA 89:12038-12042, 1993
8. Gerbitz KD, van den Ouweland JMW, Massen JA, Jaksch M: Mitochondrial diabetes mellitus: a review Biochim Biophys Acta 1271:253-260, 1995
9. Duchen MR, Smith PA, Ashcroft FM: Substrate-dependent changes in mitochondrial function, intracellular free calcium concentration and membrane channels in pancreatic β-cells Biochem J 294:35-42, 1993
10. Kiranadi B, Bangham JA, Smith PA: Inhibition of electrical activity in mouse pancreatic β-cells by the ATP/ADP translocator inhibitor, bongkrekic acid. FEBS Lett 283:93-90, 1991
11. Ashcroft FM: Adenosine 5′-triphosphate-sensitive potassium channels. Annu Rev Neurosci 11 97-118, 1988
12. Ghosh A, Ronner P, Cheong E, Khalid P, Matschinsky FM: The role of ATP and free ADP in metabolic coupling during fuel-stimulated insulin release from islet b-cells in the isolated perfused rat pancreas. J Biol Chem 266:22887-22892, 1991
13. Henquin JC, Gembal M, Detimary ZY, Gao C, Warnotte C, Gillon P. Multisite control of insulin release by glucose. Diabete & Metab 20:132-137, 1994
14. 31P NMR using surface coils. Nature 283:167-170, 1980
15. Balaban RS, Heinemann FW: Control of mitochondrial respiration in the heart in vivo. Mol Cell Biochem 89:191-197, 1989
16. Grossbrand L, Schimke RT: Multiple hexokinases of rat tissues: purification and comparison of soluble forms. J Biol Chem 241:3546-3560, 1966
17. Ureta T: The comparative isozymology of vertebrate hexokinases. Comp Biochem Physiol 71B:549-562, 1982
18. Wilson JE: Regulation of mammalian hexokinase activity. In Regulation of Carbohydrate Metabolism Vol 1. Beitner R, Ed. Boca Raton, FL, CRC Press, 1985, p. 45-85
19. Malaisse-Langae F, Malaisse W: Hexokinase metabolism in pancreatic islets: regulation of mitochondrial binding. Biochem. Med Metab Biol 39:80-89, 1988
20. Müller G, Korndörfer A, Kornak U, Malaisse WJ: Porin proteins in mitochondria from rat pancreatic islet cells and white adipocytes: identification and regulation of hexokinase binding by sulfonylurea Glimepiride. Arch Biochem Biophys 308:8-23, 1994
21. Koranyi LI, Tanizawa Y, Welling CM, Rabin DU, Permutt MA: Human islet glucokinase gene: isolation and sequence analysis of full-length cDNA. Diabetes 41:807-811, 1992
22. Polakis PG, Wilson JE: An intact hydrophobic N-terminal sequence is critical for binding of rat brain hexokinase to mitochondria. Arch Biochem Biophys 234:341-352, 1984
23. Fiek CH, Benz R, Roos N, Brdiczka D: Evidence for identity between the hexokinase-binding protein and the mitochondrial porin in the outer membrane of rat liver mitochondria. Biochem Biophys Acta 688:429-440, 1982
24. Lindén M, Gellerfors P, Nelson BD: Pore protein and the hexokinase-binding protein from the outer membrane of rat liver mitochondria are identical. FEBS Lett 141:189-192, 1982
25. Borrebaek B, Spydevold O. The effect of insulin and glucose on mitochondrial bound hexokinase activity of rat epididymal adipose tissue. Diabetologia 5:42-43, 1969
26. Goncharova NY, Zelenia EV: Influence of insulin on the catalytic activity of hexokinase isozyme II of rat skeletal muscles. Biokhimiya 56.913-922, 1991
27. Russell RR III, Mrus JM, Mommessin JI, Taegtmeyer H: Compartmentation of hexokinase in rat heart: a critical factor for tracer kinetic analysis of myocardial metabolism. Clin Invest 90.1972-1977, 1992
28. Weiler U, Riesinger I, Knoll G, Brdiczka D. The regulation of mitochondrial-bound hexokinases in the liver. Biochem. Med 33:223-236, 1985
29. Adams V, Bosch W, Hämmerle TH, Brdiczka D: Activation of low Km hexokinases in purified hepatocytes by binding to mitochondria. Biochim Biophys Acta 932:195-205, 1988
30. m form of hexokinase from various rat tissues. Biochem Biophys Res Commun 24:531-536, 1965
31. Printz RL, Koch S, Potter LR, O'Doherty RM, Tiesinga JJ, Moritz S, Granner DK: Hexokinase II mRNA and gene structure, regulation by insulin and evolution J Biol Chem 268:5209-5219, 1993
32. Braithwaite SS, Palazuk B, Colca JR, Edwards CW III, Hofmann C: Reduced expression of hexokinase II in insulin-resistant diabetes. Diabetes 44:43-48, 1995
33. Ohlendieck K, Riesinger I, Adams V, Krause J, Brdiczka D: Enrichment and biochemical characterization of boundary membrane contact sites in rat-liver mitochondria. Biochim Biophys Acta 860:672-689, 1980
34. Kottke M, Adams V, Riesinger I, Bremm G, Bosch W, Brdiczka D, Sandri G, Panfili E: Mitochondrial boundary membrane contact sites in brain: points of hexokinase and creatine kinase location and of control of Ca2+ transport. Biochim Biophys Acta 395:807-832, 1988
35. Ardail D, Lermé F, Louisot P: Further characterization of mitochondrial contact sites: effects of short-chain alcohols on membrane fluidity and activity. Biochem Biophys Res Commun 173:878-885, 1990
36. Wicker U, Bücheler K, Gellerich FN, Wagner M, Kapischke M, Brdiczka D: Effect of macromolecules on the structure of the mitochondrial inter-membrane space and the regulation of hexokinase. Biochim Biophys Acta 1142:228-239, 1993
37. Xie G, Wilson JE: Tetrameric structure of mitochondrially bound rat brain hexokinase: a crosslinklng study. Arch Biochem Biophys 276:285-293, 1990
38. Brdiczka D, Wicker U, Gellerich F: The function of the outer membrane pore in the regulation of peripheral kinases and energy metabolism. In Molecular Biology of Mitochondrial Transport Systems. NATO ASI Series Vol. H83. Forte M, Colombini M, Eds. Springer Verlag, Berlin Heidelberg, 1994 p. 297-311
39. Brdiczka D: Function of the outer mitochondrial compartment in regulation of energy metabolism. Biochim. Biophys Acta 1187:264-269, 1994
40. Knoll G, Brdiczka D: Changes in freeze-fracture mitochondrial membranes correlated to their energetic state. Biochim Biophys Acta 733:102-110, 1983
41. Bücheler K, Adams V, Brdiczka D: Localization of the ATP/ADP translocator in the inner membrane and regulation of contact sites between mitochondrial envelope membranes by ADP: a study on freeze fractured isolated liver mitochondria. Biochim Biophys Acta 1061:215-225, 1991
42. Gots RE, Gorin FA, Bessman SP: Kinetic enhancement of bound hexokinase activity by mitochondrial respiration. Biochem Biophys Res Commun 49:1249-1255, 1972
43. Bessman SP: The hexokinase-mitochondrial binding theory of insulin action, Lipman Symposium: Energy, Biosynthesis and Regulation in Molecular Biology. Berlin, New York, de Gryter, 1974, p. 77-88
44. Kabir F, Nelson BD: Hexokinase bound to rat brain mitochondria uses externally added ATP more efficiently than internally generated ATP. Biochim Biophys Acta 1057:147-150, 1991
45. Laterveer FD, Gellerich F, Gnaiger E, Nicolay K: Macromolecules increase the channeling of ADP from mitochondrially associated hexokinase to the mitochondrial matrix. In Modern Trends in Biothermokinetics 3. Gnaiger E, Gellerich FN, Wyss M, Eds. New York, Plenum, 1994, p. 186-190
46. Veech RL, Lawson JWR, Cornell NM, Krebs HA: Cytosolic phosphorylation potential. J Biol Chem 254:6538-6547, 1979
47. Brdiczka D, Knoll G, Riesinger I, Weiler U, Klug G, Benz R, Krause J: Microcompartmentation at the mitochondrial surface: its function in metabolic regulation. In Myocardial and Sceletal Muscle Bioenergetics. Brautbar N, Ed. New York, Plenum, 1986, p. 55-69
48. McCabe ERB: Microcompartmentation of energy metabolism at the outer mitochondrial membrane: role in diabetes mellitus and other diseases. J Bioenerg Biomembr 26:317-325, 1994
49. Gellerich FN, Wagner M, Kapischke M, Wicker U, Brdiczka D: Effect of macromolecules on the regulation of the mitochondrial outer membrane pore and the activity of adenylate kinase in the inter-membrane space. Biochim Biophys Acta 1142:217-227, 1993
50. Brdiczka D, Wallimann T: The importance of the outer mitochondrial compartment in regulation of energy metabolism. Mol Cell Biochem 133/134:69-83, 1994
51. Wallimann TH, Wyss M, Brdiczka D, Nicolay K: Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the "phosphocreatine circuit" for cellular energy homeostasis. Biochem J 281:21-40, 1992
52. 2+ pump function. Am J Physiol 267:C357-C366, 1994
53. 2+ uptake and regulate local ATP/ADP ratios. J Biol Chem 265:5208-5266, 1990
54. Saks V, Lipina NV, Sharov VG, Smirnov VN, Chazov EI, Grosse R: The localization of the MM isozyme of creatine phosphokinase on the surface membrane of myocardial cells and its functional coupling to ouabain-inhibited (N,K)-ATPase. Biochim Biophys Acta 465:350-358, 1977
55. Wallimann T, Schlösser T, Eppenberger HM: Function of M-line bound creatine kinase as intramyofibrillar ATP regenerator at the receiving end of the phosphocreatine shuttle in muscle J Biol Chem 259:5238-5246, 1984
56. Arnold H, Pette D: Binding of aldolase and triosephosphatdehydrogenase to F-actin and modification of catalytic properties of aldolase. Eur J Biochem 15:360-366, 1970
57. Dillon PF, Clark JF: The theory of diazymes and functional coupling of pyruvate kinase and creatine kinase. J Theor Biol 143:275-284, 1990
58. White KC, Babbitt PC, Buechter DD, Kenyon GL: The principle islet of the Coho Salmon (Oncohyncus kisutch) contains BB isoenzyme of creatine kinase. J Protein Chem 11:489-494, 1992
59. Wallimann T, Hemmer W: Creatine kinase in non-muscle tissues and cells. Mol Cell Biochem 133/134:193-220, 1994
60. Anderson S, Bankier AT, Barrell BGH, de Bruin MHL, Coulson AR, Drouin J, Eperon IC, Nierlich DP, Roe BA, Sanner F, Schreier PH, Smith AJH, Staden K, Younf IG: Sequence and organisation of the human mitochondrial genome. Nature 290:457-465, 1981
61. Richter C, Park JW, Ames BN: Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc Natl Acad Sci USA 85:6465-6467, 1988
62. Wallace DC: Diseases of the mitochondrial DNA. Annu Rev Biochem 61:1175-1212, 1992
63. Wallace DC: Mitochondrial DNA sequence variation in human evolution and disease. Proc Natl Acad Sci USA 91:8739-8746, 1994
64. Moraes CT, Ciacci F, Bonilla E, Jansen C, Hirano M, Rao N, Lovelace RE, Rowland LP, Schon EA, DiMauro S: Two novel pathogenic mitochondrial DNA mutations affecting organelle number and protein synthesis: is the transferRNALeu(UUR) gene an etiologic hot spot? J Clin Invest 92:2909-2915, 1993
65. Morton KJ, Cooper JM, Brown KG, Lake BD, Pike D, Poulton J: A new point mutation associated with mitochondrial encephalomyopathy. Hum Mol Genet 2:2081-2087, 1993
66. Leu(UUR). Lancet 338: 143-147, 1991
67. Silvestri G, Moraes CT, Shanske S, Oh SJ, DiMauro S: A new mtDNA mutation in the tRNA lys gene associated with myoclonic epilepsy and ragged red fibers. Am J Hum Genet 51:1213-1217, 1992
68. van den Ouweland JMW, Lemkes HHPJ, Ruitenbeek W, Sandkuijl LA, de Vijlder MF, Struyvenberg PAA, van de Kamp JJP, Maassen JA: Mutation in mitochondrial tRNALeu(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nature Genet 1:308-371, 1992
69. Reardon W, Ross RJM, Sweeney MG, Luxon LM, Pembrey ME, Harding AE, Trembath RC: Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA. Lancet 340:1376-1379, 1992
70. Leu(UUR) gene. FEBS Lett 321.194-196, 1993
71. Sue CM, Holmes-Walker DJ, Morris JGL, Boyages SC, Cummins DS, Byrne E: Mitochondrial gene mutation and diabetes mellitus. Lancet 341:437-438, 1993
72. Schulz JB, Klockgether T, Dichgans J, Seibel P, Reichmann H: Mitochondrial gene mutations and diabetes mellitus Lancet 341:438-439, 1993
73. Leu(UUR) gene. Lancet 341:1291-1292, 1993
74. Vionnet N, Passa P, Froguel P: Prevalence of mitochondrial gene mutations in families with diabetes mellitus. Lancet 342:1429-1430, 1993
75. Kadowaki T, Kadowaki H, Mori Y, Tobe K, Sakuta R, Suzuki Y, Tanabe Y, Sakura H, Awata T, Goto Y, Hayakawa T, Matsuoka K, Kawamori R, Kamada T, Horai S, Nonaka I, Hagura R, Akanuma Y, Yazaki Y: A subtype of diabetes associated with a mutation of the mitochondrial DNA. N Engl J Med 330:962-968, 1994
76. Katagiri H, Asano T, Ishihara H, Inukai K, Anai M, Yamanouchi T, Tsukuda K, Kikuchi M, Kitaoka H, Ohsawa N, Yazaki Y, Oka Y: Mitochondrial diabetes mellitus: prevalence and clinical characterization of diabetes due to mitochondrial tRNALeu(UUR) gene mutation in Japanese patients. Diabetologia 37:504-510, 1994
77. Alcolado JC, Majid A, Brockington M, Sweeney MG, Morgan R, Rees A, Harding AE, Barnett AH: Mitochondrial gene defects in patients with NIDDM Diabetologia 37:372-376, 1994
78. Hattersley AT, Dronsfietd MJ, Smith PR, Kumar S, Johnson A, Barnett AH, Dodson PM, Bain SC: Mitochondrial mutations are an important cause of insulin-treated diabetes and deafness. Diabetic Med 11 (Suppl. 1):S45, 1994
79. Walker M, Taylor RW, Stewart MW, Bindoff LA, Jackson MJ, Humphriss DB, Alberti KGMM, Turnbull DM: Decreased insulin secretion in subjects with the mitochondrial 3243 tRNALeu(UUR) mutation. Diabetic Med 11 (Suppl. 1):A17 (S7), 1994
80. Oka Y, Katagiri H, Tshihara H, Asano T, Kikuchi M, Kobayashi T: Mitochondrial diabetes mellitus: glucose-induced signaling defects and beta-cell loss. Muscle and Nerve (Suppl. 3):S131-S136, 1995
81. van den Ouweland JMW, Lemkes HPJ, Trembath RC, Ross R, Velho G, Cohen D, Froguel P, Maassen JA: Maternally inherited diabetes and deafness is a distinct subtype of diabetes and associates with a single point mutation in the mitochondrial tRNALeu(UUR) gene. Diabetes 43:746-751, 1994
82. Orushi H, Inoe K, Osaka H, Kimura S, Nagatomo H, Hanihara T. Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) and diabetes, a molecular genetic analysis and family study. J Neurol Sci 114:205-208, 1993
83. Hart L, Lemkes HHPJ, Heine RJ, Stolk RP, Feskens EJM, Jansen JJ, Van der Does FFE, Grobbee DE, Kromhout D, van den Ouweland JMW, Maassen JA: Prevalence of maternally inherited diabetes and deafness in diabetic populations in the Netherlands. Diabetologia 37:1169-1170, 1994
84. Goto Y: Clinical features of MELAS and mitochondrial DNA mutations. Muscle and Nervre (Suppl. 3):S107-S112, 1995
85. Kadowaki T, Sakura H, Otabe S, Yasuda K, Kadowaki H, Mori Y, Hugura R, Akauuma Y, Yazaki Y: A subtype of diabetes mellitus associated with a mutation in the autodondrial gene. Muscle and Nerve (Suppl 3):S137-S147, 1995
86. Leu(UUR) gene: a study in seven families with mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS). Diabetologia 37:818-825, 1994
87. Otabe S, Sakura H, Shimokawa K, Kadowaki H, Yasuda K, Nonaka K, Hagura R, Akanuma Y, Yazaki Y, Kadowaki T: The high prevalence of the diabetic patients with a mutation in the mitochondrial gene in Japan J Clin Endocrinol Metab 79:768-771, 1994
88. Leu(UUR) gene point mutation. Muscle and Nerve (Suppl. 3):S124-S130, 1995
89. Lys mutation: Cell 61:931-937, 1990
90. Lys mutation. Diabetes Care 17:1428-1432, 1994
91. Hao H, Bonilla E, Manfredi G, DiMauro S, Moraes CT: Segregation patterns of a novel mutation in the mitochondrial tRNA glutamic acid gene associated with myopathy and diabetes. Am J Hum Genet 56.117-125, 1995
92. Hanna MG, Nelson I, Sweeney MG, Cooper JM, Watkins PJ, Morgan-Hughes JA, Harding AE: Congenital encephalomyopathy and adult-onset myopathy and diabetes mellitus: different phenotypic associations of a new heteroplasmic mtDNA tRNA glutamic acid mutation. Am J Hum Genet 56:1026-1033, 1995
93. Holt IJ, Harding AE, Morgan-Hughes JA: Deletion of the muscle mitochondrial DNA in patient with mitochondrial myopathies. Nature 331: 717-719, 1988
94. Lestienne P, Ponsot G: Kearns-Sayre syndrome with muscle mitochondrial DNA deletion (Letter). Lancet i:885, 1988
95. Nelson I, Degoul F, Obermaier-Kusser B, Romero N, Borrone C, Marsac C, Vayssiere-JL, Gerbitz KD, Fardeau M, Ponsot G, Lestienne P. Mapping of heteroplasmic mitochondrial DNA deletions in Kearns-Sayre syndrome. Nucleic Acids Res 17:8117-8124, 1989
96. Moraes CT, DiMauro S, Zeviani M, Lombes A, Shanske S, Miranda AF, Nakase H, Bonilla E, Werneck LC, Servidei S, Nonaka I, Koga Y, Spiro AJ, Brownell AKW, Schmidt B, Schotland DL, Zupane M, DeVivo DC, Schon EA, Rowland LP: Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N Engl J Med 320:1293-1299, 1980
97. Gerbitz KD, Obermaier-Kusser B, Zierz S, Pongratz D, Müller-Höcker J, Lestienne P: Mitochondrial myopathies: divergences in genetic deletions, biochemical defects and the clinical symptoms. J Neurol 237:5-10, 1990
98. Gerbitz KD, Obermaier-Kusser B, Lostienne P, Zierz S, Muller-Hocker J, Pongratz D, Paetzke-Brunner I, Deufel T: Mutations of the mitochondrial DNA: the contribution of DNA techniques to the diagnosis of mitochondrial encephalomyopathies J Clin Chem Clin Biochem 28:241-250, 1991
99. Tanabe Y, Miyamoto S, Kinoshita Y, Yamada K, Sasaki N, Makino E, Nakajima H: Diabetes in Kearns-Sayre syndrome. Eur Neurol 28:34-38, 1988
100. Harvey JN, Barnett D: Endocrine dysfunction in Kearns-Sayre syndrome. Clin Endocrinol 37:97-104, 1992
101. Quade A, Zierz S, Klingmüller D: Endocrine abnormalities in mitochondrial myopathy with external ophthalmoplegia. Clin Invest 70:396-402, 1992
102. Poulton J, Deadman ME, Bindoff L, Morton K, Land J, Brown G: Families of mitochondrial re-arrangements can be detected in patients with mtDNA deletions: duplications may be a transient intermediate form. Hum Mol Genet 2:23-30, 1993
103. Dunbar DR, Moonie PA, Swingler RJ, Davidson D, Roberts R, Holt IJ: Maternally transmitted partial direct tandem duplication of mitochondrial DNA associated with diabetes mellitus. Hum Mat Genet 2:1619-1624, 1993
104. Poulton J, Morten KJ, Weber K, Brown GK, Bindoff L: Are duplications of mitochondrial DNA characteristic of Kearns-Sayre syndrome? Hum Mol Genet 3:947-951, 1994
105. Poulton P, Holt U: Mitochondrial DND. does more lead to less? Nature Genet 8:313-315, 1994
106. Rotig A, Bessis JL, Romero N, Cormier V, Saudubray JM, Narcy P, Lenoir Rustin P, Munnich A: Maternally inherited duplication of the mitochondrial genome in a syndrome of proximal tubulopathy, diabetes mellitus and cerebellar ataxia. Am J Hum Genet 50:368-371, 1992
107. Majander A, Suomaleinen A, Vettenranta K, Sarioly H, Perkkio M, Holmberg C, Pihko H: Congenital hypoplastic anemia, diabetes and severe renal tubular dysfunction associated with a mitochondrial DNA deletion. Pediatr Res 30:327-330, 1991
108. Superti-Furga A, Schoenle E, Tuchschmid P, Caduff R, Sabato V, DeMattia D, Gitzelmann R, Steinmann B: Pearsons bone marrow pancreas syndrome with insulin-dependent diabetes mellitus, progressive renal tubulopathy, organic aciduria, and elevated fetal hemoglobin caused by deletion and duplication of the mitochondrial DNA. Eur J Pediatr 152:44-50, 1993
109. Ballinger SW, Shoffner JM, Hedaya EV, Trounce I, Polak MA, Wallace DC: Maternally transmitted diabetes and deafness with a 10.4 Kb mitochondrial DNA deletion. Nature Genet 1:11-15, 1992
110. Ballinger SW, Shoffner JM, Gebhart S, Koontz DA, Wallace DC: Mitochondrial diabetes revisited. Nature Genet 7:458-459, 1994
111. Brockington M, Sweeney MG, Hammans SR, Morgan-Hughes JA, Harding AE: A tandem duplication in the D-loop of human mitochondrial DNA is associated with deletions in mitochondrial myopathies. Nature Genet 4:67-71, 1993
112. Torroni A, Lott MT, Cabell MF, Chen YS, Lavergne L, Wallace DC: mtDNA and the origin of Caucasians: identification of ancient Caucasian-specific haplogroups, one of which is prone to a recurrent somatic duplication in the D-loop region. Am J Hum Genet 55:760-776, 1994
113. Jaksch M, Hofmann S, Bezold R, Kaufhold P, Mertens S, Gerbitz KD: Point mutations and duplications of the mitochondrial DNA in an unselected collective with diabetes mellitus (Abstract). Herbsttagung der Dt Ges Biol Chemie 376:S111, 1995
114. Obermaier-Kusser B, Müller-Hocker J, Nelson I, Lestienne P, Enter C, Riedele T, Gerbitz KD: Different copy numbers of apparently identically deleted mitochondrial DNA in tissues from a patient with Kearns-Sayre syndrome detected by PCR. Biochem Biophys Res Commun 169:1007-1015, 1990
115. Jaksch M, Hofmann S, Kaufhold P, Obermaier-Kusser B, Zierz S, Gerbitz KD: A novel ND1 mutation (T>C at nt pos 3398) of the mtDNA in a familiy with MELAS, cardiomyopathy and diabetes mellitus. Hum Mut. In press
116. Suomalainen A, Kaukonen J, Amati P, Timonen R, Haltia M, Weissenbach J, Zeviani M, Somer H, Peltonen L: An autosomal locus predisposing to deletions of mitochondrial DNA. Nature Genet 9:146-151, 1995
117. Suzuki S, Hinoldo Y, Hirai S, Ohtomo M, Onoda M, Matsumoto M, Satoh Y, Akai H, Suzuki H, Abe K, Miyabayashi S, Toyota T: Mitochondrial DNA Mutations in the Pancreatic β-Cells in Diabetes Mellitus 15th Meeting of the International Diabetes Federation (IDF), 1994, Kobe, Japan, abstract 11A30P2004
118. Poulton J, O'Rahilly S, Morton KJ, Clark A. Mitochondrial DNA, diabetes and pancreatic pathology in Kearns-Sayre syndrome. Diabetologia 38:869-871, 1995
119. Oka Y, Katagiri H, Yazaki Y, Murase T, Kobayaski T: Mitochondrial gene mutation in islet-cell-antibody positive who were initially non-insulin dependent diabetes. Lancet 342:527-528, 1993
120. Muller-Höcker J, Seibel P, Schneidenbanger K, Zietz C, Obermaier-Kusser B, Gerbitz KD, Kadenbach B: In situ hybridisation of mitochondrial DNA in the heart of a patient with Kearns-Sayre syndrome and dilatative cardiomyopathy. Hum Pathol 23: 1431-1437, 1992
121. Stadhouders AM, Jap PH, Winkler HP, Eppenberger HM, Wallimann T: Mitochondrial creatine kinase: a major constituent of pathological inclusions seen in mitochondrial myopathies. Proc Natl Acad Sci USA 91:5089-5093, 1994
122. Eppenberger-Eberhardt M, Riesinger I, Messerli M, Schwarb P, Müller M, Eppenberger HM, Wallimann T: Adult rat cardiomyocytes in creatine-deficient medium display large mitochondria with paracrystalline inculsions, enriched for creatine kinase. J Cell Biol 113:289-302, 1991
123. King MP, Attardi G. Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. Science 246:500-503, 1989
124. Hayashi JI, Ohta S, Kikuchi A, Takemitsu M, Goto Y, Nonake I: Introduction of disease-related mitochondrial DNA deletions into HeLa cells lacking mitochondrial DNA results in mitochondrial dysfunction. Proc Natl Acad Sci USA 88:10614-10618, 1991
125. van den Ouweland JMW A New Subtype of Non-Insulin-Dependent Diabetes Mellitus Is Associated With a Mitochondrial Gene Mutation. PhD thesis. Netherlands, University of Leiden, 1994
126. Bokvist K, Eliasson L, Rorsman P: Co-localization of L-type Ca2+ channels and insulin-containing secretory granules and its significance for the initiation of exocytosis in mouse pancreatic B-cells. EMBO J 14:50-57, 1995
127. 2+ to supramicrimolar levels in a pancreatic β-cell line. J Biol Chem 268:22385-22390, 1993
128. Moudy AM, Handran SD, Goldberg MP, Ruffin N, Karl I, Kranz-Eble P, DeVivo DC, Rothman SM: Abnormal calcium homeostasis and mitochondrial polarization in a human encephalomyopathy. Proc Natl Acad Sci USA 92:729-733, 1995
129. Karasik A, O'Hara C, Srikanta S, Swift M, Soeldner JS, Kahn CR, Herskowitz RD: Genetically programmed selective islet β-cell loss in diabetic subjects with Wolfram's syndrome. Diabetes Care 12:135-138, 1989
130. Bu X, Rotter JI: Wolfram syndrome: a mitochondrial mediated disorder. Lancet 342:598-600, 1993
131. Bezold R, Hofmann S, Jaksch M, Kaufhold P, Gerbitz KD: DIDMOAD or Wolfram syndrome: a mitochondrial-mediated disorder? Diabetes Care 18:583-584, 1995
132. Cortopassi G, Wang E: Modeling the effects of age-related mtDNA mutation accumulation: complex I deficiency, superoide and cell death. Biochim Biophys Acta 1271:171-176, 1995
133. Korsemeyer SJ, Yin XM, Oltvai ZN, Veis-Novack DJ, Linette JP: Reactive oxygen species and the regulation of cell death by the Bcl-2 gene family. Biochim Biophys Acta 1271:63-66, 1995
134. Malaisse WJ, Malaisse-Lague F, Sener A, Pipeleers DG: Determinants of selective toxicity of alloxan to the pancreatic β-cell. Proc Natl Acad Sci USA 79:927-930, 1982
135. Hagenfeld L, von Dobeln U, Solders G, Kaijser L: Creatine treatment in MELAS. Muscle and Nerve 17:1236-1237, 1994
136. Antonetti DA, Reynet C, Kahn CR: Increased expression of mitochondrial-encoded genes in skeletal muscle of humans with diabetes mellitus. J Clin Invest 95:1383-1388, 1995
137. Laakso M, Malkki M, Deeb SS: Amino acid substitutions in hexokinase II among patients with NIDDM. Diabetes 44:330-334, 1995
138. 142 His substitution. Diabetes 44:340-346, 1995
139. Echwald SM, Bjorbaek C, Hansen T, Clansen JO, Vestergaard H, Zierath JR, Printz RL, Granner DK, Pedersen O Identification of four amino acid substitutions in hexokinase II and studies of the relationships to NIDDM, glucose effectiveness, and insulin sensitivity. Diabetes, 44.347-353, 1995
140. Rothman DL, Magnusson I, Cline G, Gerard D, Kahn CR, Shulman RG, Shulman GI: Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 92:983-987, 1995
141. Huizing M, Ruitenbeek W, Thinnes FP, DePinto V: Lack of voltage-dependent anion channel in human mitochondrial myopathies (Letter). Lancet 344:762, 1994
142. Malaisse WJ: Non-insulin dependent diabetes mellitus and islet B-cell mitochondrial glycerophosphate dehydrogenase deficiency. Diabetic Med 12:479-481, 1995
143. Sekine N, Cirulli V, Regazzi R, Brown LJ, Gine E, Tamarit-Rodriguez J, Girotti M, Marine S, MacDonald MJ, Wollheim CB, Rutter GA: Low lactate dehydrogenase and high mitochondrial glycerol phosphat dehydrogenase in pancreatic β-cells. J Biol Chem 269:4895-4902, 1994
144. Chen S, Ogawa A, Ohneda M, Unger RH, Foster DW, McGarry JD: More direct evidence for a malonyl-CoA-carnitine palmitoyltransferase I interaction as a key event in pancreatic β-cell signaling. Diabetes 43:878-883, 1994
145. 2+ in the release of pancreatic islet hormones. Diabete & Metab 20:123-131, 1994
146. Kramer R, Palmieri F: Metabolite carriers in mitochondria. In Molecular Mechanism in Bioenergetics. Ernster L, Ed. New York, Elsevier, 1992, p. 359-385
147. Klingenberg M: Molecular aspects of the adenine nucleotide carrier from mitochondria. Arch Biochem Biophys 270:1-14, 1989
148. Schein SJ, Colombini M, Finkelstein A: Reconstitution in planar bilayers of a voltage dependent anion-selective channel obtained from parametium mitochondria. J Membr Biol 30:99-120, 1976
149. Benz R, Brdiczka D: The cation-selective substrate of the mitochondrial outer membrane pore: single-channel conductance and influence on intermembrane and peripheral kinases. J Bioenerg Biomembr 24:313-39, 1992
150. Nicholls DG, Ferguson SJ: Bioenergetics 2. New York, Academy Press, 1992
151. Marcillat O, Goldschmidt D, Eichenberger D, Vial C: Only one of the two interconvertable forms of the mitochondrial creatine kinase binds to heart mitoplasts. Biochim Biophys Acta 890:233-241, 1987